| Net Cash Provided by (Used in) Operating Activities |
-19,132 |
USD |
-2.2% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
20,000 |
USD |
+3% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
150,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
868 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
229 |
USD |
-94.9% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
1,495,289 |
USD |
+2% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
1,495,289 |
USD |
+2% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
14,000,000 |
shares |
-30% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
5,182,022 |
USD |
+5.2% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
7,644,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Amortization of Intangible Assets |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Interest Expense |
73,091 |
USD |
+8.2% |
Q2 2023 |
Q2 2023 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |